1Van de Water A, Janssens W, Van Neuten J, et al.Pharmacological and hemodynamie profile of nebivolol, a chemically novel, potent, and selective β1-adrenergic antagonist [J]. J Cardiovasc Pharmacol, 1988, 11(5):552-563.
3Kim MH, Devlin WH, Das SK, et al. Effects of β-adrenergie blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy[J]. Circulation, 1999, 100(7) : 729-735.
4Mangrella M, Rossi F, Fici F, et al. Pharmacology of nebivolol[J]. Pharmacol Res, 1998, 38(6):419-431.
5Koizumi T, Saito Y. Preparation of 6-fluoro-4-chro-manone-2-carboxylic acid as intermediate for aldose reductase inhibitors [P]. JP: 02218674, 1990-08-31.(CA 1991, 114:122058t).
6Kurono M, Baba Y, Unno R, et al. Manufacture of optically active (S)-4-oxochroman-2-carboxylic acid derivatives[P]. JP:6092956, 1994-04-05. (CA 1994,121 : 157527s).
7Xhonneux RM, Van Lommen GRE. Agents for lowering the blood pressure [P]. EP: 334429, 1989-09-27. (CA 1990, 113:126609a).
8Johannes CW, Visser MS, Weatherhead GS, et al.Zr-catalyzed kinetic resolution of allylic ethers and Mo-catalyzed chromene formation in synthesis.Enantioselective total synthesis of the antihypertensive agent (S, R, R, R)-nebivolol [J]. J Am Chem Soc, 1998,120(33) :8340-8347.
9Barrett AGM, Hamprecht D, Ohkubo M. Dess-Martin periodinane oxidation of alcohols in the presence of stabilized phosphorus ylides: a convenient method for the homologation of alcohols via unstable aldehydes [J]. J Org Chem, 1997, 62(26):9376-9378.
10Chandrasekhar S, Venkat Reddy M. Enantioselectire total synthesis of the antihypertensive agent (S,R , R , R )-nebivolol [J]. Tetrahedron , 2000, 56(34) :6339-6344.
